Completed PHASE2 INTERVENTIONAL 2-arm NCT01242592

Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis

Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis: Randomized Placebo Controlled Trial

Sponsor: NMP Medical Research Institute

Conditions Pulmonary Tuberculosis

Interventions Anti-Tuberculosis Treatment

Updated 4 times since 2017 Last updated: Nov 16, 2010 Started: Feb 28, 2005 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Pulmonary Tuberculosis, this trial is completed. The trial is conducted by NMP Medical Research Institute and has accumulated 4 data snapshots since 2005. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NMP Medical Research Institute

Data source: NMP Medical Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jaipur, India